Funding
PYTHAGORAS II (4.2.1.ε1) 'Evaluation of Immune Responses Against Highly Expressed Tumor Antigens in Lung Adenocarcinoma' Co-funded by the European Union-European Social Fund 75%) & National Resources-EPEAK II (25%). Approved Jan 2005. |
|
| IRTALUNG (021795) 'Evaluation of Immune Responses Against Highly Expressed Tumor Antigens in Non-Small Cell Lung Carcinoma' Supported by a Marie Curie Incoming International Fellowship within the 6th European Community Framework Programme. Approved Nov 2005. |
|
| ENTEP2004 (04EP09) 'Selection of Immunostimulating Overexpressed Tumor Antigens/Epitopes in Lung Cancer Adenocarcinoma' Co-financed by E.U.-European Social Fund (75%), the Greek Ministry of Development-GSRT (25%) & Private Sector ANTISEL. Approved Apr 2006. |
|
| EΠΑν (05NOV-EU-445) 'Immunoepigenetics of Adenocarcinoma: Impact on Succesful Cancer Immunotherapy' Co-financed by E.U.-European Social Fund (70%), the Greek Ministry of Development-GSRT (30%) & Private Sector ANTISEL. Approved Jun 2006. |
|
| IMMUNOEPIGENETICS (046459) 'Anti-tumor CD8 Immunity Influenced by Epigenetic Alterations' Supported by a Marie Curie International Reintegration Grant within the 6th European Community Framework Programme. Aprroved Oct 2006. |
|
| GRANT IN AID 'Immunology Research' Supported by Phizer Hellas. Approved Nov 2005. |
|
| MATCHING FUNDS Approved Dec 2007. |
|
AMGEN HELLAS DONATION
|
|
   |